Chronic Lymphocytic Leukemia Fund Grant

The Chronic Lymphocytic Leukemia Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients battling chronic lymphocytic leukemia (CLL). This fund provides essential support for prescription copays and premiums, ensuring that patients can access necessary treatments without the stress of financial constraints. Since its inception, the foundation has awarded over $1.2 billion in grants, helping more than 1.1 million patients. The initiative emphasizes the importance of accessible healthcare and aims to improve the quality of life for those affected by this condition.

Note:  If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund.
In 2024, we awarded more than $1.2 billion in grants through our Disease Funds, and since 2004 we have helped more than 1,100,000 patients afford essential treatments and medications. HealthWell is recognized as one of America’s most efficient charities — 100 percent of every dollar donated goes directly to patient grants and services.
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of chronic lymphocytic leukemia.
Grant Utilization
HealthWell estimates that patients use an average of $3,200 during their 12-month grant period for this disease area.
Assistance Type
Prescription Drug CopayInsurance premium (Medicare Part B only)
Treatments Covered
AlemtuzumabArzerraBelrapzoBendamustine HydrochlorideBendekaBetamethasoneBetamethasone Acetate-betamethasone Sodium PhosphateBetamethasone Sodium PhosphateBreyanziBrukinsaCalquenceCelestone SoluspanChlorambucilCladribineCopiktraCortefCortisone AcetateCyclophosphamideCytarabineDecadronDex24DexamethasoneDexamethasone Sodium PhosphateDoxorubicin HydrochlorideDuvelisibDxevoEtopophosEtoposideEtoposide PhosphateFludarabine PhosphateFusilevGazyvaHemadyHidexHydrocortisoneHydrocortisone Sodium SuccinateIbutrinibIdamycin PfsIdarubicin HydrochlorideIdelalisibImbruvicaJaypircaJylamvoKenalog-10KeytrudaKhapzoryLemtradaLenalidomideLeucovorin CalciumLeukeranLevoleucovorinLevoleucovorin CalciumLisocabtagene MaraleucelMechlorethamine HydrochlorideMedrolMethotrexateMethylprednisoloneMethylprednisolone Sodium SuccinateMillipredNipentNivolumabObinutuzumabOpdivoOrapred OdtOtrexupOxaliplatinPediapredPembrolizumabPentostatinPirtobrutinibPrednisolonePrednisolone Sodium PhosphatePrednisonePro-c-dure 5 KitRasuvoRayosRevlimidRiabniRituxanRituxan HycelaRituximabRituximab And Hyaluronidase HumanRituximab-abbsRituximab-arrxRituximab-pvvrRuxienceSolu-cortefSolu-medrolTaperdexTevimbraTislelizumab-jsgrTreandaTrexallTriamcinoloneTruximaVenclextaVenetoclaxVeripred 20Vincristine SulfateVivimustaXatmepZ-cort 7-dayZanubrutinibZydelig

Eligibility

Do I Qualify?HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:You are being treated for Chronic Lymphocytic Leukemia.We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature.The patient must receive treatment in the United States.You have insurance and it covers your medication.To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. Your income falls within our guidelines.HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level.Household Income Limit500% of the Federal Poverty Level(adjusted for household size and high cost of living areas)The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.You are receiving treatment in the United States.Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

Ineligibility

The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.